New cancer drug trial tests experimental treatment for tough tumors

NCT ID NCT07182149

Summary

This early-stage study is testing whether an experimental drug called NRM-823 is safe and can help control advanced cancers that have stopped responding to standard treatments. Researchers will give NRM-823 alone and combined with immunotherapy to about 150 adults with various solid tumors. The main goal is to find the safest dose and see how well patients tolerate the treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Normunity Investigational Site

    RECRUITING

    Denver, Colorado, 80220, United States

  • Normunity Investigational Site

    RECRUITING

    New Haven, Connecticut, 06519, United States

  • Normunity Investigational Site

    RECRUITING

    Minneapolis, Minnesota, 55425, United States

  • Normunity Investigational Site

    RECRUITING

    Maumee, Ohio, 43537, United States

  • Normunity Investigational Site

    RECRUITING

    Philadelphia, Pennsylvania, 19107, United States

  • Normunity Investigational Site

    RECRUITING

    Nashville, Tennessee, 37203, United States

  • Normunity Investigational Site

    RECRUITING

    Dallas, Texas, 75230, United States

  • Normunity Investigational Site

    RECRUITING

    San Antonio, Texas, 78229, United States

  • Normunity Investigational Site

    RECRUITING

    Fairfax, Virginia, 22031, United States

Conditions

Explore the condition pages connected to this study.